DRI Benzodiazepine Assay
K-Number: K173963 · 2018-02-21
Device Summary
Frequently Asked Questions
What is the DRI Benzodiazepine Assay?
DRI Benzodiazepine Assay is a medical device that received FDA 510(k) clearance on 2018-02-21. The listed applicant is Microgenics Corporation. The 510(k) number is K173963.
When did DRI Benzodiazepine Assay receive FDA 510(k) clearance?
DRI Benzodiazepine Assay received FDA 510(k) clearance on 2018-02-21, under 510(k) number K173963.
Who is the listed applicant for DRI Benzodiazepine Assay?
The FDA 510(k) record lists Microgenics Corporation as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for DRI Benzodiazepine Assay?
The FDA product code for DRI Benzodiazepine Assay is JXM.
Other records listing Microgenics Corporation as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: JXM)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.